Sientra Gains $65M

Santa Barbara-based Sientra, a developer of FDA-approved, silicone breast implants, said Wednesday that it has raised $65M in a Series C funding round. The funding was led by Abingworth, and also included Clarus Ventures, OrbiMed Advisors, and all of its other current investors. The round will go towards commercialization of its products. Sientra said the new round brings its total raised to $151M. The firm was founded by CEO Hani Zeini. More information »